Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.
作者信息
Ryall R D
出版信息
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):133-4. doi: 10.1016/0360-3016(78)90128-1.
PMID:632140
Abstract
摘要
相似文献
1
Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):133-4. doi: 10.1016/0360-3016(78)90128-1.
2
Radiotherapy combined with ICRF 159 (NSC 129943).
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8.
3
A clinical evaluation of ICRF 159 as a radiosensitising agent.
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):127-31. doi: 10.1016/0360-3016(78)90127-x.
4
[Clinical experiences with radiotherapy and ICRF 159 in sarcomas].
Strahlentherapie Sonderb. 1978;75:110-4.
5
Preliminary report on AT1727 as a potential radiosensitizer.
Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2305-7. doi: 10.1016/0360-3016(84)90237-2.
6
Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.
Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1077-84. doi: 10.1016/s0360-3016(96)00433-6.
7
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
Cancer. 1978 Jan;41(1):100-7. doi: 10.1002/1097-0142(197801)41:1<100::aid-cncr2820410115>3.0.co;2-p.
8
Combination of radiation and razoxane (ICRF 159) in vivo.
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):109-13. doi: 10.1016/0360-3016(78)90124-4.
9
Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115-9. doi: 10.1016/0360-3016(78)90125-6.
10
Radiation as a therapeutic modality in sarcomas of the soft tissue.
Hematol Oncol Clin North Am. 1995 Aug;9(4):733-46.
Zotero 插件